Mumbai: Sahajanand Medical Technologies Limited (“Company”) has fixed the price band at Rs 327/- to Rs 344/- per Equity Share for its initial public offering of Equity Shares.

The Initial Public Offering (“IPO” or “Offer”) of the Company will open on Thursday, October 15, 2026, for subscription and close on Monday, October 19, 2026.

Investors can bid for a minimum of 43 Equity Shares and in multiples of 43 Equity Shares thereafter.

Equity shares outstanding as on date 101,646,778 Equity Shares.

The IPO comprises an offer for sale of up to 13,822,116 Equity Shares of face value of Re 1 each by the Company’s Promoter, Shree Hari Trust; a member of the Promoter Group, Dhirajkumar Savjibhai Vasoya; and the following Investor Selling Shareholders: Samara Capital Markets Holding Limited, Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding B.V.

The offer includes a reservation of up to 250,000 Equity Shares for subscription by eligible employees (the “Employee Reservation Portion”). The Offer less the Employee Reservation Portion is referred to as the “Net Offer”.

The Offer is being made through the book-building process, in line with SEBI ICDR Regulations, with not more than 50% of the Net Offer reserved for Qualified Institutional Buyers (QIBs), not less than 15% of the Net Offer for Non-Institutional Bidders (NIBs), and not less than 35% of the Net Offer for Retail Individual Bidders (RIBs).

Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited are the book-running lead managers to the Offer, and MUFG Intime India Private Limited is the registrar to the Offer.

The equity shares are proposed to be listed on NSE and BSE.